A Cell-Delivered and –Activated SN38-Dextran Prodrug Increases Survival in a Murine Disseminated Pancreatic Cancer Model

Enzyme activated prodrugs have been investigated and sought after as highly specific, low side effect treatments, especially for cancer therapy. Unfortunately, excellent targets for enzyme activated therapy are rare. Here we demonstrate a system based on cell delivery that can carry both a prodrug a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Basel, Matthew T., Balivada, Sivasai, Shrestha, Tej B., Seo, Gwi-Moon, Pyle, Marla M., Tamura, Masaaki, Bossmann, Stefan H., Troyer, Deryl L.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583224/
https://ncbi.nlm.nih.gov/pubmed/22238072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201101879
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items